Yes, Pat, there is the exclusivity clause with Gerresheimer, but that doesn't necessarily mean an agreement will take that long to conclude. License and royalty fees with global pharma will underpin everything moving forward. Once this is locked in, other agreements will fall into place. The amounts involved will raise eyebrows leaving all the sceptics scrambling to get on board.
Yes, Pat, there is the exclusivity clause with Gerresheimer, but...
Add UNI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.61 |
Change
-0.070(0.91%) |
Mkt cap ! $583.8M | |||
| Open | High | Low | Value | Volume |
| $7.68 | $7.82 | $7.59 | $949.3K | 123.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 680 | $7.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.66 | 403 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| UNI (ASX) Chart |